| Literature DB >> 34151190 |
Koichi Tomoshige1, Tsuchiya Tomoshi1, Matsumoto Keitaro1, Takuro Miyazaki1, Ryoichiro Doi1, Ryusuke Machino1, Satoshi Mizoguchi1, Takamune Matumoto1, Yutaka Maeda2, Takeshi Nagayasu1.
Abstract
Mucinous adenocarcinoma of the thymus is a particularly rare type among thymic carcinomas. Here, we report a patient who underwent complete surgical resection of the primary mucinous adenocarcinoma of the thymus. She was 74 years old and presented with a 60-mm multilocular cystic tumor in her right anterior mediastinum. We performed extended thymo-thymectomy with partial resection of the right upper lobe and pathologically diagnosed the patient with Masaoka stage II mucinous adenocarcinoma of the thymus. Immunohistochemistry showed the absence of PD-L1, suggesting that immune check point inhibitors targeting PD-1/PD-L1 might not be effective in this case. The increased preoperative serum levels of CA19-9 decreased after the operation. CA19-9 is a biomarker for disease status. Future reports should help elucidate the pathogenesis of this disease.Entities:
Keywords: CA19-9; extended thymo-thymectomy; mucinous adenocarcinoma; thymic carcinoma
Year: 2021 PMID: 34151190 PMCID: PMC8211018 DOI: 10.1007/s42399-021-00839-x
Source DB: PubMed Journal: SN Compr Clin Med ISSN: 2523-8973